ENANTA PHARMACEUTICALS, INC Deferred Tax Assets, Operating Loss Carryforwards
ENANTA PHARMACEUTICALS, INC (ENTA) had Deferred Tax Assets, Operating Loss Carryforwards of $14.78 million as of 2025-09-30, per its 10-K filed 2025-11-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-11-19
- 2025-09-30: Deferred Tax Assets, Operating Loss Carryforwards $14.78M.
- 2024-09-30: Deferred Tax Assets, Operating Loss Carryforwards $7.27M.
- 2023-09-30: Deferred Tax Assets, Operating Loss Carryforwards $43.00K.
- 2022-09-30: Deferred Tax Assets, Operating Loss Carryforwards $29.11M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-09-30 | $14.78M 10-K · filed 2025-11-19 |
| 2024-09-30 | $7.27M 10-K · filed 2025-11-19 |
| 2023-09-30 | $43.00K 10-K · filed 2024-11-27 |
| 2022-09-30 | $29.11M 10-K · filed 2023-11-22 |
| 2021-09-30 | $3.10M 10-K · filed 2022-11-23 |
| 2020-09-30 | $861.00K 10-K · filed 2021-11-24 |
| 2014-09-30 | $2.95M 10-K · filed 2015-12-11 |
| 2013-09-30 | $8.49M 10-K · filed 2014-12-11 |
| 2012-09-30 | $10.96M 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |